GH Research (GHRS) Retained Earnings (2021 - 2025)
GH Research (GHRS) recorded quarterly Retained Earnings of -$23.0 million in Q4 2025, down 314.34% quarter-over-quarter from $10.7 million in Q3 2025, and down 81.11% on a YoY basis from -$121.5 million in Q4 2024.
GH Research (GHRS) Retained Earnings (2021 - 2025) Analysis & Trends
GH Research's Retained Earnings history runs 5 years deep, the most recent figure standing at -$23.0 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 81.11% year-over-year to -$23.0 million; the TTM figure through Dec 2025 stood at -$23.0 million (down 81.11% YoY), while the FY2025 annual figure was -$23.0 million, down 81.11% from the prior year.
- Retained Earnings was -$23.0 million for Q4 2025 at GH Research, down from $10.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $10.7 million in Q3 2025 to a low of -$23.0 million in Q4 2025.
- Historically, Retained Earnings has averaged -$442555.6 across 5 years, with a median of $2.8 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings jumped 1104.58% in 2022, then tumbled 372.48% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$16.4 million in 2021, then grew by 24.24% to -$12.4 million in 2022, then soared by 137.49% to $4.7 million in 2023, then slumped by 372.48% to -$12.7 million in 2024, then slumped by 81.11% to -$23.0 million in 2025.
- The last three Retained Earnings figures came in at -$23.0 million (Q4 2025), $10.7 million (Q3 2025), and $8.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | -22.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.95 Mn |
| Sep 30, 2025 | 10.71 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 6.67 Mn |
| Dec 31, 2024 | -12.67 Mn |
| Sep 30, 2024 | 4.87 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 4.29 Mn |
| Dec 31, 2023 | 4.65 Mn |
| Sep 30, 2023 | 2.89 Mn |
| Jun 30, 2023 | 2.81 Mn |
| Mar 31, 2023 | 3.87 Mn |
| Dec 31, 2022 | -12.41 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 693,000.00 |
| Dec 31, 2021 | -16.37 Mn |
| Sep 30, 2021 | 131,000.00 |